Nimbus Therapeutics’ Research Collaboration and License Agreement with Eli Lilly and Co.

Goodwin Procter advised Nimbus Therapeutics on the deal.Nimbus Therapeutics announced its Research Collaboration and License Agreement with Eli Lilly and Company for the exclusive and worldwide development…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now